Smartleaf Asset Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
Other funds holding BPMC
IA
HNB
Smartleaf Asset Management's BPMC Position: Q3 2025 in Review
Smartleaf Asset Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 94 shares — an estimated $12K sold.
Smartleaf Asset Management first reported a position in BPMC in Q2 2024 and held it in 5 quarters. The position peaked at $16.9K in Q4 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Smartleaf Asset Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Smartleaf Asset Management sold 94 Blueprint Medicines shares in Q3 2025, an estimated $12K.
- Smartleaf Asset Management first reported a position in Blueprint Medicines in Q2 2024 and held it in 5 quarters.
- Smartleaf Asset Management's Blueprint Medicines position peaked at $16.9K in Q4 2024.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Smartleaf Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.